Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2022

Net Loss Per Share

Schedule of basic and diluted net loss per share

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands, except share and per share data)	2022		2021		2022		2021
Numerator:
Net loss attributable to CASI Pharmaceuticals, Inc.	$	(7,680)		(6,946)	$	(16,276)	$	(20,829)
Denominator:
Weighted average number of common stock		13,606,130		13,979,636		13,700,282		13,235,128
Denominator for basic and diluted net loss per share calculation		13,606,130		13,979,636		13,700,282		13,235,128
Net loss per share
— Basic and diluted	$	(0.56)	$	(0.50)	$	(1.19)	$	(1.57)